back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-11 13:06 Tx date 2024-04-01 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
835,000 | |
| Filed 2024-03-25 16:55 Tx date 2024-03-21 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,100
+35,000 vol $0.06 each |
795,000 | |
| Filed 2024-03-25 16:49 Tx date 2024-03-21 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,100
-35,000 vol $0.06 each |
490,000 | |
| Filed 2024-02-01 16:14 Tx date 2024-01-24 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,500
+140,000 vol $0.075 each |
1,490,000 | |
| Filed 2024-02-01 16:08 Tx date 2024-01-24 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,500
-140,000 vol $0.075 each |
1,975,000 | |
| Filed 2023-06-29 15:10 Tx date 2023-06-28 |
$AVCR
Avricore Health Inc. |
Teahen, Thomas Wilfrid
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-06-29 15:09 Tx date 2023-06-21 |
$AVCR
Avricore Health Inc. |
Teahen, Thomas Wilfrid
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-29 12:50 Tx date 2023-06-28 |
$AVCR
Avricore Health Inc. |
Hrudka, Christine Jean
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
| Filed 2023-06-29 12:46 Tx date 2023-06-21 |
$AVCR
Avricore Health Inc. |
Hrudka, Christine Jean
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-21 16:29 Tx date 2023-06-21 |
$AVCR
Avricore Health Inc. |
Hrudka, Christine Jean
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,500 | ||
| Filed 2023-05-18 13:43 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,975,000 | |
| Filed 2023-05-16 16:43 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
525,000 | |
| Filed 2023-05-16 16:37 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,300 vol |
720,300 | |
| Filed 2023-05-16 16:31 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
2,115,000 | |
| Filed 2023-05-16 16:26 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
890,000 | |
| Filed 2023-05-16 16:23 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
700,000 | |
| Filed 2023-05-16 16:17 Tx date 2023-05-15 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2023-04-25 17:43 Tx date 2023-04-10 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
4,461,111 | |
| Filed 2023-04-25 17:33 Tx date 2023-04-10 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
1,675,000 | |
| Filed 2023-03-16 12:14 Tx date 2023-03-13 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,000
+200,000 vol $0.10 each |
760,000 | |
| Filed 2023-03-16 12:11 Tx date 2023-03-13 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,000
-200,000 vol $0.10 each |
325,000 | |
| Filed 2023-03-01 13:39 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
1,367,618 | |
| Filed 2023-03-01 13:37 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
||
| Filed 2023-03-01 13:28 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
25,000 | |
| Filed 2023-03-01 13:23 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
||
| Filed 2022-12-09 14:31 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
||
| Filed 2022-12-09 14:21 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
||
| Filed 2022-12-09 14:31 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$2,500
+25,000 vol $0.10 each |
225,000 | |
| Filed 2022-12-09 14:28 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,500
-25,000 vol $0.10 each |
200,000 | |
| Filed 2022-12-09 14:21 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$60,000
+600,000 vol $0.10 each |
1,240,000 | |
| Filed 2022-12-09 14:16 Tx date 2022-12-08 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-600,000 vol $0.10 each |
640,000 | |
| Filed 2022-09-20 16:51 Tx date 2022-01-28 |
$AVCR
Avricore Health Inc. |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-350,000 vol |
0 | |
| Filed 2022-08-12 18:32 Tx date 2022-07-20 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
100,000 | |
| Filed 2022-08-12 18:32 Tx date 2022-07-20 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-150,000 vol |
100,000 | |
| Filed 2022-08-12 16:41 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
585,000 | |
| Filed 2022-08-12 16:34 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
525,000 | |
| Filed 2022-08-12 16:27 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
1,240,000 | |
| Filed 2022-08-12 16:18 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
500,000 | |
| Filed 2022-08-12 16:06 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
375,000 | |
| Filed 2022-08-12 01:05 Tx date 2022-08-10 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
1,825,000 | |
| Filed 2022-08-12 01:00 Tx date 2022-01-28 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-350,000 vol |
0 | |
| Filed 2022-08-12 00:58 Tx date 2021-12-09 |
$AVCR
Avricore Health Inc. |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
350,000 | |
| Filed 2022-07-26 14:00 Tx date 2022-01-28 |
$AVCR
Avricore Health Inc. |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-180,000 vol |
0 | |
| Filed 2022-07-26 13:35 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-333,333 vol |
0 | |
| Filed 2021-11-18 16:26 Tx date 2021-11-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$37,500
+250,000 vol $0.15 each |
1,350,000 | |
| Filed 2021-11-18 16:20 Tx date 2021-11-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-37,500
-250,000 vol $0.15 each |
350,000 | |
| Filed 2021-10-22 15:55 Tx date 2021-02-23 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,000
+50,000 vol $0.46 each |
910,000 | |
| Filed 2021-09-22 13:46 Tx date 2021-07-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$42,000
+280,000 vol $0.15 each |
560,000 | |
| Filed 2021-09-22 13:42 Tx date 2021-07-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-42,000
-280,000 vol $0.15 each |
0 | |
| Filed 2021-09-22 13:27 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-42,000
-280,000 vol $0.15 each |
||
| Filed 2021-09-13 15:58 Tx date 2021-09-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,100
-45,000 vol $0.18 each |
0 | |
| Filed 2021-08-17 12:15 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,500
-180,000 vol $0.175 each |
567,618 | |
| Filed 2021-08-17 11:47 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,500
-180,000 vol $0.175 each |
620,000 | |
| Filed 2021-08-16 17:56 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-500,000 vol $0.175 each |
||
| Filed 2021-08-16 17:19 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,000
-200,000 vol $0.175 each |
||
| Filed 2021-08-16 20:10 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-444,000 vol |
180,000 | |
| Filed 2021-08-16 18:21 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$17,400
+116,000 vol $0.15 each |
866,000 | |
| Filed 2021-08-16 18:15 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-17,400
-116,000 vol $0.15 each |
624,000 | |
| Filed 2021-08-16 18:09 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,600
-110,000 vol $0.16 each |
750,000 | |
| Filed 2021-08-16 17:56 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-87,500
-500,000 vol $0.175 each |
300,000 | |
| Filed 2021-08-16 17:50 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$75,000
+500,000 vol $0.15 each |
800,000 | |
| Filed 2021-08-16 17:37 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-75,000
-500,000 vol $0.15 each |
0 | |
| Filed 2021-08-16 17:27 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$30,000
+200,000 vol $0.15 each |
747,618 | |
| Filed 2021-08-16 17:24 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-30,000
-200,000 vol $0.15 each |
333,333 | |
| Filed 2021-08-16 17:19 Tx date 2021-08-12 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,000
-200,000 vol $0.175 each |
547,618 | |
| Filed 2021-08-16 17:06 Tx date 2021-08-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-500,000 vol |
||
| Filed 2021-05-28 13:03 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,125,000 | |
| Filed 2021-05-27 20:01 Tx date 2021-01-27 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+350,000 vol |
450,000 | |
| Filed 2021-05-27 19:51 Tx date 2021-01-27 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+350,000 vol $0.10 each |
4,311,111 | |
| Filed 2021-05-27 19:43 Tx date 2020-04-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
| Filed 2020-07-07 16:43 Tx date 2020-04-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-19 23:40 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
790,000 | |
| Filed 2021-04-19 22:18 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
435,000 | |
| Filed 2021-04-19 22:14 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,115,000 | |
| Filed 2021-04-19 22:11 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
400,000 | |
| Filed 2021-04-19 22:02 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
375,000 | |
| Filed 2021-04-19 21:59 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
400,000 | |
| Filed 2021-04-19 21:59 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:54 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:54 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:45 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
||
| Filed 2021-04-19 21:45 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
375,000 | |
| Filed 2021-04-19 21:34 Tx date 2021-04-19 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
250,000 | |
| Filed 2021-04-19 21:21 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
||
| Filed 2021-04-19 21:21 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
1,115,000 | |
| Filed 2021-04-19 20:49 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
||
| Filed 2021-04-19 20:49 Tx date 2021-03-22 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
435,000 | |
| Filed 2021-03-17 14:45 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+243,000 vol |
||
| Filed 2021-03-17 14:38 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
||
| Filed 2021-02-18 02:41 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+243,000 vol |
||
| Filed 2021-02-18 02:34 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
||
| Filed 2021-03-05 16:36 Tx date 2020-10-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-98,083.37
-891,667 vol $0.11 each |
0 | |
| Filed 2021-03-05 16:35 Tx date 2020-10-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,000
-200,000 vol $0.11 each |
891,667 | |
| Filed 2021-03-05 16:35 Tx date 2020-10-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,000
-25,000 vol $0.12 each |
1,091,667 | |
| Filed 2021-03-05 16:33 Tx date 2020-10-07 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,500
-50,000 vol $0.13 each |
1,116,667 | |
| Filed 2021-03-05 16:32 Tx date 2020-10-05 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Emerald Health Therapeutics, Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,000
-500,000 vol $0.15 each |
1,166,667 | |
| Filed 2021-02-22 20:34 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$500.00
+10,000 vol $0.05 each |
45,000 | |
| Filed 2021-02-22 20:32 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-500.00
-10,000 vol $0.05 each |
175,000 | |
| Filed 2021-02-22 20:25 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$2,100
+35,000 vol $0.06 each |
35,000 | |
| Filed 2021-02-22 20:22 Tx date 2021-02-18 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,100
-35,000 vol $0.06 each |
185,000 | |
| Filed 2021-02-18 02:41 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+243,000 vol |
453,000 | |
| Filed 2021-02-18 02:34 Tx date 2021-02-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+425,000 vol |
1,215,000 | |
| Filed 2021-02-11 01:11 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+180,000 vol |
740,000 | |
| Filed 2021-02-11 01:07 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$18,000
+180,000 vol $0.10 each |
860,000 | |
| Filed 2021-02-11 00:59 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+350,000 vol |
600,000 | |
| Filed 2021-02-11 00:55 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+350,000 vol $0.10 each |
1,100,000 | |
| Filed 2021-02-11 00:07 Tx date 2021-02-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-31,275
-69,500 vol $0.45 each |
300,000 | |
| Filed 2021-01-29 18:41 Tx date 2020-11-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,500
-100,000 vol $0.085 each |
400,000 | |
| Filed 2021-01-29 18:36 Tx date 2021-01-25 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfield, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,930
-30,500 vol $0.26 each |
369,500 | |
| Filed 2021-01-11 21:25 Tx date 2020-12-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
790,000 | |
| Filed 2021-01-11 21:14 Tx date 2020-12-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+210,000 vol |
210,000 | |
| Filed 2021-01-11 21:06 Tx date 2020-12-08 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+700,000 vol |
||
| Filed 2020-12-16 19:21 Tx date 2020-11-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+100,000 vol |
100,000 | |
| Filed 2020-12-16 18:47 Tx date 2020-04-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-16 16:23 Tx date 2020-11-13 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+100,000 vol $0.10 each |
3,961,111 | |
| Filed 2020-11-23 00:45 Tx date 2020-11-20 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+250,000 vol |
250,000 | |
| Filed 2020-11-23 00:43 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-23 00:40 Tx date 2020-11-20 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+250,000 vol $0.10 each |
750,000 | |
| Filed 2020-11-17 20:31 Tx date 2020-11-16 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
1,033,334 | |
| Filed 2020-11-17 20:26 Tx date 2020-11-16 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |
2,061,333 | |
| Filed 2020-10-02 19:07 Tx date 2020-10-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,250
+105,000 vol $0.05 each |
680,000 | |
| Filed 2020-10-02 19:05 Tx date 2020-10-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,250
-105,000 vol $0.05 each |
0 | |
| Filed 2020-09-28 15:08 Tx date 2020-09-24 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,000
-150,000 vol $0.12 each |
575,000 | |
| Filed 2020-09-24 23:18 Tx date 2020-09-23 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,750
-250,000 vol $0.095 each |
3,861,111 | |
| Filed 2020-07-16 17:50 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$12,500
+500,000 vol $0.025 each |
4,111,111 | |
| Filed 2020-07-10 21:01 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,500
+500,000 vol $0.025 each |
500,000 | |
| Filed 2020-07-10 21:00 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-10 20:36 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$12,500
+500,000 vol $0.025 each |
500,000 | |
| Filed 2020-07-10 20:36 Tx date 2015-06-05 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-10 20:30 Tx date 2020-07-10 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+400,000 vol $0.025 each |
1,861,333 | |
| Filed 2020-07-07 16:43 Tx date 2020-04-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2020-07-07 16:39 Tx date 2020-04-02 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Seccombe, Rodger McKendry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,611,111 | ||
| Filed 2020-06-16 13:33 Tx date 2020-06-16 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,225
-35,000 vol $0.035 each |
725,000 | |
| Filed 2019-11-25 18:00 Tx date 2019-11-25 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+200,000 vol $0.02 each |
760,000 | |
| Filed 2019-11-25 17:54 Tx date 2019-11-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-100,000 vol $0.07 each |
||
| Filed 2019-11-25 17:25 Tx date 2019-11-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,000
-100,000 vol $0.07 each |
||
| Filed 2019-11-01 23:14 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
290,000 | |
| Filed 2019-11-01 23:08 Tx date 2019-10-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Bremner, Hector Dennis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
140,000 | ||
| Filed 2019-10-31 21:38 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
220,000 | |
| Filed 2019-10-31 21:33 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+105,000 vol |
105,000 | |
| Filed 2019-10-31 21:32 Tx date 2019-08-06 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-31 21:26 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2019-10-31 21:25 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-31 21:16 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
715,000 | |
| Filed 2019-10-31 21:05 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
325,000 | |
| Filed 2019-10-31 20:58 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,026,072 | |
| Filed 2019-08-16 23:49 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$42,000
+280,000 vol $0.15 each |
280,000 | |
| Filed 2019-08-16 23:47 Tx date 2018-03-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:47 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$14,000
+280,000 vol $0.05 each |
280,000 | |
| Filed 2019-08-16 23:46 Tx date 2018-03-21 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:42 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
| Filed 2019-08-16 23:40 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:37 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2019-08-16 23:36 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:17 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$84,000
+560,000 vol $0.15 each |
560,000 | |
| Filed 2019-08-16 23:15 Tx date 2019-08-06 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:12 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$28,000
+560,000 vol $0.05 each |
560,000 | |
| Filed 2019-08-16 23:11 Tx date 2019-08-06 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Smith, Kiriaki
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:03 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+200,000 vol $0.15 each |
533,333 | |
| Filed 2019-08-16 22:56 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+200,000 vol $0.05 each |
747,618 | |
| Filed 2019-08-15 17:29 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+500,000 vol |
833,334 | |
| Filed 2019-08-15 17:22 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
1,461,333 | |
| Filed 2019-06-24 14:43 Tx date 2019-06-24 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-37,180
-169,000 vol $0.22 each |
876,072 | |
| Filed 2019-06-13 11:01 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Arnstein, Alan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100
+35,000 vol $0.06 each |
210,000 | |
| Filed 2019-06-13 10:57 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+400,000 vol $0.06 each |
1,045,072 | |
| Filed 2019-06-13 10:52 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Sindelar, Robert David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100
+35,000 vol $0.06 each |
235,000 | |
| Filed 2019-06-13 10:47 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Guorgui, Sherif Seif
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,100
+35,000 vol $0.06 each |
210,000 | |
| Filed 2019-06-13 10:41 Tx date 2019-04-01 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,300
+55,000 vol $0.06 each |
655,000 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,099
+358,571 vol $0.07 each |
961,333 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Hall, David M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$14,999
+214,285 vol $0.07 each |
547,618 | |
| Filed 2019-02-15 Tx date 2019-02-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,699.84
-73,928 vol $0.28 each |
645,072 | |
| Filed 2019-02-15 Tx date 2019-02-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Rai, Sukhwinder
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,699
+73,928 vol $0.28 each |
602,762 |